VIR Historical PE Ratio image   This VIR PE ratio history page last updated 11/7/2022
VIR Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/3/2022
21.801.305.204.2
Q2 2022
8/9/2022
28.84-0.58-2.32NA
Q1 2022
5/5/2022
20.843.8515.401.4
Q4 2021
2/24/2022
28.223.9215.681.8
Q3 2021
11/4/2021
36.680.823.2811.2
Q2 2021
8/5/2021
37.710.461.8420.5
Q1 2021
5/6/2021
41.61-1.32-5.28NA
Q4 2020
2/25/2021
64.11-0.83-3.32NA
Q3 2020
11/10/2020
25.84-0.67-2.68NA
Q2 2020
8/11/2020
52.66-0.27-1.08NA
Q1 2020
5/12/2020
30.26-0.71-2.84NA
Q4 2019
3/26/2020
32.00-0.71-2.84NA
Q3 2019
11/19/2019
12.85-4.60-18.40NA
VIR PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/3/2022
21.801.308.492.6
Q2 2022
8/9/2022
28.84-0.588.013.6
Q1 2022
5/5/2022
20.843.859.052.3
Q4 2021
2/24/2022
28.223.923.887.3
Q3 2021
11/4/2021
36.680.82-0.87NA
Q2 2021
8/5/2021
37.710.46-2.36NA
Q1 2021
5/6/2021
41.61-1.32-3.09NA
Q4 2020
2/25/2021
64.11-0.83-2.48NA
Q3 2020
11/10/2020
25.84-0.67-2.36NA
Q2 2020
8/11/2020
52.66-0.27-6.29NA
Q1 2020
5/12/2020
30.26-0.71NANA
Q4 2019
3/26/2020
32.00-0.71NANA
Q3 2019
11/19/2019
12.85-4.60NANA
Quotes delayed 20 minutes

Email EnvelopeFree VIR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Vir Biotechnology (VIR) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

VIRI PE Ratio History
VIRX PE Ratio History
VIVE PE Ratio History
VIVO PE Ratio History
VKTX PE Ratio History
VLON PE Ratio History
VNDA PE Ratio History
VOR PE Ratio History
VRAY PE Ratio History
VRCA PE Ratio History
How should the VIR historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Vir Biotechnology. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this VIR Historical PE Ratio page.

What is the average historical PE for VIR based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The VIR historical PE ratio using the annualized quarterly earnings method works out to 7.8.

What is the average historical PE for VIR based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The VIR historical PE ratio using the TTM earnings method works out to 4.0.

What is the average historical PE for VIR based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The VIR historical PE ratio using the annualized median TTM earnings method works out to 10.32.

On this page we presented the VIR Historical PE Ratio information for Vir Biotechnology' stock. The average VIR historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 7.8. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average VIR historical PE based on this TTM earnings result method is 4.0. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this VIR historical PE result, against the recent PE: when this page was posted on 11/4/2022, the most recent closing price for VIR had been 25.66, and the most recent quarterly earnings result, annualized, was 5.2. Meanwhile, the most recent TTM earnings summed to 8.49. From these numbers, we calculate the recent VIR PE on 11/4/2022 based on annualized quarterly EPS was 4.9. Based on VIR's history, that recent PE is low relative to the historical average, with the recent PE 37.2% lower than the historical average PE across our data set for Vir Biotechnology. Looking at the recent VIR PE on 11/4/2022 based on TTM EPS, we calculate the ratio at 3.0. Based on VIR's history, that recent PE is low relative to the historical average, with the recent PE 25.0% lower than the average PE across our Vir Biotechnology data set with TTM EPS used in the calculation at each period.

Another interesting VIR historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for VIR, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for VIR, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.58, 1.30, 3.85, and 3.92. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 1.30 and 3.85 — which gives us the median of 2.58. Basically the way to think about this 2.58 number is this: for the trailing four earnings reports, 2.58 marks the "middle ground" number where VIR has reported a value higher than 2.58 half the time, and has reported a value lower than 2.58 half the time. Annualizing that median value then gets us to 10.32/share, which we use as the denominator in our next PE calculation. With 25.66 as the numerator (as of 11/4/2022), the calculation is then 25.66 / 10.32 = 2.5 as the VIR PE ratio as of 11/4/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on VIR or any other given stock, valuation analysis for VIR can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Vir Biotechnology PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for VIR. Thanks for visiting, and the next time you need to research VIR Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: CMPS Options Chain, VFL Videos, Institutional Holders of ALF.

 

VIR Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.